Vaccines and Related Biological Products Advisory Committee
September 22, 2005 Meeting
Date and Time:
The meeting will be held via teleconference on September 22, 2005 from 1:30 to 5:00 pm.
Location:
National Institutes of Health, Food and Drug Administration, Building 29B, Conference Room C, 8800 Rockville Pike, Bethesda, MD. 20892. This meeting will be held by teleconference. The public is welcome to attend the meeting at the above location. A speakerphone will be provided at the specified location for public participation in this meeting.
Contact Persons:
Christine Walsh, R.N., or Denise Royster, 301-827-0314, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512391. Please call the Information Line for up-to-date information on this meeting.
Agenda:
The Committee will hear an overview on the Laboratory of Retroviruses and the Laboratory of Immunoregulation, Division of Viral Products, and the Laboratory of Respiratory & Special Pathogens and the Laboratory of Methods Development & Quality Control, Division of Bacterial Parasitic & Allergenic Products, Office of Vaccines Research and Review, CBER, and in closed session will discuss the reports from the Laboratory Site Visits of April 18-19, 2005, and June 16, 2005.
Oral Presentations:
Between approximately 3:00 and 4:00 pm oral presentations from the public will be scheduled. Those desiring to make formal oral presentations should notify the contact person before September 15, 2005.
Closed Committee Deliberations:
From approximately 4:00 to 5:00 pm the meeting will be closed to permit discussion where disclosure would constitute a clearly unwarranted invasion of personal privacy (5 U.S.C. 552b(c) (6)). The Committee will discuss a review of internal research programs in the Office of Vaccines Research and Review, Division of Viral Products and Division of Bacterial Parasitic & Allergenic Products, CBER.
|
